Opendata, web and dolomites

CHBTECH SIGNED

Sulphur-free production method for non-food biopolymers (dissolving pulp, hemicellulose and lignin)

Total Cost €

0

EC-Contrib. €

0

Partnership

0

Views

0

Project "CHBTECH" data sheet

The following table provides information about the project.

Coordinator
CH-BIOFORCE OY 

Organization address
address: AHVENTIE 4 A 21
city: ESPOO
postcode: 2170
website: n.a.

contact info
title: n.a.
name: n.a.
surname: n.a.
function: n.a.
email: n.a.
telephone: n.a.
fax: n.a.

 Coordinator Country Finland [FI]
 Total cost 3˙061˙250 €
 EC max contribution 2˙142˙875 € (70%)
 Programme 1. H2020-EU.3. (PRIORITY 'Societal challenges)
2. H2020-EU.2.3. (INDUSTRIAL LEADERSHIP - Innovation In SMEs)
3. H2020-EU.2.1. (INDUSTRIAL LEADERSHIP - Leadership in enabling and industrial technologies)
 Code Call H2020-SMEInst-2018-2020-2
 Funding Scheme SME-2
 Starting year 2019
 Duration (year-month-day) from 2019-03-01   to  2021-02-28

 Partnership

Take a look of project's partnership.

# participants  country  role  EC contrib. [€] 
1    CH-BIOFORCE OY FI (ESPOO) coordinator 2˙142˙875.00

Map

 Project objective

Wood-based biomass is one of the richest sources of bio-chemicals on Earth. Of the main constituents of wood – cellulose (40-50%), hemicellulose (20-30%) and lignin (20-30%) – mainly cellulose/pulp is utilised today. Rest of the biomass is disposed as waste. The main obstacle for wider use and further development of these hemicellulose and lignin is the lack of availability. Furthermore, current fractionation methods (based on Kraft process) use sulphur, which destroys the material properties of valuable bio-chemicals. CH-Bioforce Oy has developed a sulphur-free biomass fractionation technology, which allows the extraction of all three wood-based biomass constituents in an economically sound way, with extremely high purity, and in industrial scale. Technology is flexible in size, and can utilize practically any kind of wood as raw material, e.g., birch, pine, spruce, eucalyptus, even wheat straw and bagasse. The process works well even with low quality wood, such as sawdust and logging residues, which are not suitable for commonly used pulping processes. CH-Bioforce´s technology offers a renewable and cost-competitive option to replace fossil and food-based raw materials in a wide variety of applications, e.g in textiles, chemicals, and plastics. Company has conducted an intensive material testing and evaluation for dissolving pulp, polymeric hemicellulose and sulphur-free lignin produced by their pilot plants, and has already attracted several global corporations in energy, pulp&paper, and chemical industries. Business model for CH-Bioforce is to licence its technology to companies, who aim to produce and sell bio-based raw materials. Aim of this proposed project is to develop CH-Bioforce´s technology from current TRL-7 to TRL-9, to prepare the business scale up, and to convince the first customer to make the investment decision by the end of the project.

Are you the coordinator (or a participant) of this project? Plaese send me more information about the "CHBTECH" project.

For instance: the website url (it has not provided by EU-opendata yet), the logo, a more detailed description of the project (in plain text as a rtf file or a word file), some pictures (as picture files, not embedded into any word file), twitter account, linkedin page, etc.

Send me an  email (fabio@fabiodisconzi.com) and I put them in your project's page as son as possible.

Thanks. And then put a link of this page into your project's website.

The information about "CHBTECH" are provided by the European Opendata Portal: CORDIS opendata.

More projects from the same programme (H2020-EU.3.;H2020-EU.2.3.;H2020-EU.2.1.)

MEDIVAC (2019)

Machine learning software to design personalized neoantigen vaccines tailored to specific vaccine delivery systems

Read More  

RDNA (2019)

Empowering New Venture Growth - RDNA

Read More  

Project Tracworx (2019)

Tracworx is a data analytics tool that allows you to establish bottlenecks in your patient flow, while understanding your efficiencies and ultimately your true capacity.

Read More